OTC · GROM
Communication Services · Internet Content & Information
$0.00
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 5:05 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 3 trading sessions · Daily adjusted prices
GROM closed at $0.00 after 3 trading sessions, up 100.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 3, 2026 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 1.42K |
| Jul 31, 2026 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 1.1K |
| Jul 27, 2026 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 132.78K |
The latest Smart Investors Daily articles mentioning GROM.
GROM research
Company profile and research snapshot.
GROM SOCIAL ENTERPRS INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 18, 2023 | EF Hutton | Buy | — |
| Apr 18, 2023 | EF Hutton | Buy | — |
| Nov 11, 2022 | EF Hutton | Buy | — |
| Jul 26, 2022 | EF Hutton | Buy | — |
| Jan 13, 2022 | EF Hutton | Buy | — |
No generated briefing is available yet.
PennyStocks · Mar 8, 2024
Here's why penny stocks might be the better choice against cryptocurrency The post Should You Buy Penny Stocks or Cryptocurrency? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Benzinga · Sep 8, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 60 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 34,491.98 while the NASDAQ rose 0.49% to 13,816.50. The S&P 500, also rose, gaining, 0.24% to 4,461.81. Check This Out: Top 5 Health Care Stocks That May Explode In Q3 Leading and Lagging Sectors Energy shares jumped by 0.7% on Friday. In trading on Friday, industrials shares fell by 0.4%. Top Headline RH (NYSE: RH) reported better-than-expected second-quarter earnings on Thursday. RH reported quarterly earnings of $3.93 per share, which beat the analyst consensus estimate of $2.56, a 51.36% decrease over earnings of $8.08 per share from last year. The company reported quarterly sales of $800.48 million, which beat the analyst consensus estimate of $784.90 million, a 19.28% decrease over sales of $991.62 million in the same period last year. The company raised the low end of its revenue guidance for the full-year 2023 to a range of $3.04 billion to $3.1 billion versus the $3.07 billion estimate. Equities Trading UP Biocept, Inc. (NASDAQ: BIOC) shares shot up 81% to $1.52 after the ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning GROM.
No results
No recent SID articles mention GROM.
